跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 344 条关于
“ANCA”
全部
344
临床试验
213
药物
41
机构
15
资讯
75
去年
Amgen's Tavneos Enters Phase 3 Trial for Pediatric ANCA-Associated Vasculitis
去年
Q32 Bio Delays Phase 2 Trial of ADX-097 in ANCA-Associated Vasculitis
去年
Nkarta's NKX019 Cell Therapy Trial Opens Enrollment for ANCA-Associated Vasculitis
去年
Avacopan Demonstrates Superior Safety Profile in ANCA-Associated Vasculitis Across Multiple Clinical Trials
去年
Fasenra Approved in EU for Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis
2个月前
Mirador Therapeutics Licenses KP-301, a Long-Acting Anti-C5a Antibody, Expanding into ANCA-Associated Vasculitis
去年
Lixudebart Shows Promise in Reversing Organ Fibrosis in Phase 2 Trials
去年
Biotech Execs Face Legal Scrutiny Over Clinical Trial Result Disclosures
7个月前
Amgen Refuses FDA Request to Withdraw Rare Disease Drug Tavneos Amid Data Integrity Concerns
去年
FDA Grants Orphan Drug Designation to NS-229 for Rare Vasculitis Condition
第 1 页,共 8 页
上一页
下一页